SPLENDRIS
Live / Registered — International registration cancelled — extension of protection cancelled (as of 07 May 2023)
What this means for you
Registered since 25 Nov 2014. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79136686
- Registration number
- 4642937
- Mark type
- Stylized text
- Filed
- 07 May 2013
- Published for opposition
- 09 Sept 2014
- Registered
- 25 Nov 2014
- Attorney of record
- Timothy T. Wang
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Chemico-pharmaceutical preparations, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases; Chemical preparations for pharmaceutical purposes, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Medicines for human purposes, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Medicated troches, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Active pharmaceutical ingredients in the nature of pharmaceutical preparations, which are used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Prepared Chinese medicines, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Biochemical medicines, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Dietetic substances adapted for medical use, namely, beverages or food in the nature of vitamin, protein, minerals, lecithin, glucose, amino acid, folic acid, fruit juice, fruit oil, honey, seaweed glue, fish oil, cod-liver oil, cubilose, and mineral food-supplements, which are used for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Drugs for medical purposes, namely, medicines for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders
Owner
- SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD., 518040 Shenzhen, Guangdong, CN
- SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD., 518040 Shenzhen, Guangdong, CN
- SHENZHEN SALUBRIS; PHARMACEUTICALS CO., LTD., 518040 Shenzhen, Guangdong, CN
Prosecution history
- 26 Nov 2023 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
- 26 Nov 2023 — DEATH OF INTERNATIONAL REGISTRATION
- 11 Jul 2022 — TOTAL INVALIDATION PROCESSED BY THE IB
- 09 Jun 2022 — GENERIC MADRID TRANSACTION SENT TO IB
- 08 Jun 2022 — GENERIC MADRID TRANSACTION CREATED
- 11 Feb 2022 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 11 Jun 2021 — CANCELLED SECTION 71
- 25 Nov 2019 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 09 Oct 2019 — CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 05 Jul 2019 — CORRECTION TRANSACTION RECEIVED FROM IB
- 04 Jul 2019 — NEW REPRESENTATIVE AT IB RECEIVED
- 07 Dec 2018 — NEW REPRESENTATIVE AT IB RECEIVED
- 08 May 2015 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 20 Apr 2015 — FINAL DISPOSITION NOTICE SENT TO IB
- 20 Apr 2015 — FINAL DISPOSITION PROCESSED